Use of FK 506 in pancreas transplantation

Transplant International

Volumn 9, Issue SUPPL. 1, 1996, Pages

  Gruessner, Rainer W G ^a   Sutherland, David E R ^a   Drangstveit, Mary Beth ^a   Troppmann, Christoph ^a   Gruessner, Angelika C ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

Author keywords

FK 506; Pancreas transplantation; Tacrolimus

Indexed keywords

CYCLOSPORIN A; INSULIN; TACROLIMUS;

ADOLESCENT; ADULT; ARTICLE; B CELL LYMPHOMA; DRUG BLOOD LEVEL; FEMALE; GRAFT REJECTION; GRAFT SURVIVAL; HEADACHE; HUMAN; HYPERGLYCEMIA; IMMUNOSUPPRESSIVE TREATMENT; INFECTION; INSULIN DEPENDENT DIABETES MELLITUS; KIDNEY TRANSPLANTATION; MAINTENANCE THERAPY; MAJOR CLINICAL STUDY; MALE; NEPHROTOXICITY; NEUROTOXICITY; ORAL DRUG ADMINISTRATION; PANCREAS TRANSPLANTATION; PRIORITY JOURNAL; SCHOOL CHILD; TREATMENT OUTCOME; TREMOR;

EID: 0029853732     PISSN: 09340874     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1432-2277.1996.tb01624.x     Document Type: Article

References (9)

1. Cox KL, Lawrence-Miyaskai LS, Garcia-Kennedy R, et al (1995) An increased incidence of Epstein-Barr virus infection and lymphoproliferative disorder in young children on FK 506 after liver transplantation. Transplantation 59: 425
2. Gruessner RWG, Sutherland DER (1996) Clinical diagnosis in pancreatic allograft rejection. In: Solez K, Racusen LC, Billingham M, Dekker M (eds) Pathology and rejection diagnosis in solid organ transplantation. New York, pp 455-499
3. Hirano Y, Fujihara S, Ohara K, Katsuki S, Noguchi H (1992) Morphological and functional changes of islets of Langerhans in FK 506-treated rats. Transplantation 53: 889
4. Kaufman DC, Kaplan B, Kamwar Y, Abecassis M, Stuart F (1995) The successful use of tacrolimus (FK 506) in a pancreas/kidney transplant recipient with recurrent cyclosporine-associated hemolytic uremic syndrome. Transplantation 59: 1737-1739
5. Klintmalm G (1994) The U.S. Multi-center FK 506 Liver Study Group. A comparison of tacrolimus (FK 506) and cyclosporine for immunosuppression after liver transplantation. N Engl J Med 331: 1110
6. Reyes J, Tzakis AG, Bonet H, et al (1994) Lymphoproliferative disease after intestinal transplantation under primary FK 506 immunosuppression. Transplant Proc 26: 1426
7. Shaffer D, Simpson MA, Conway P, Madras PN, Monaco AP (1995) Normal pancreas allograft function following simultaneous pancreas kidney transplantation after rescue therapy with tacroli-mus (FK506). Transplantation 59: 1063
8. Shapiro R, Jordan ML, Scantlebury VP, et al (1995) A prospective randomized trial of FK506-based immunosuppression after renal transplantation. Transplantation 59: 485
9. Teraoka S, Babazono T, Koike T, et al (1995) Effect of rescue therapy using FK506 on relapsing rejection after combined pancreas and kidney transplantation. Transplant Proc 27: 1335